Is CONNECTDROP®, a Medication Event Monitoring System Add-On Paired with a Smartphone Application, Acceptable to Patients with Glaucoma for Taking Their Daily Medication? The CONDORE Pilot Study.

Objective: This pilot study tested the feasibility of a future efficacy trial examining the effect of CONNECTDROP®, a novel Medication Event Monitoring System (MEMS) paired with a mHealth application, on medication adherence in patients with glaucoma.

Design: A single-center, single-arm, prospective interventional pilot study (NCT04552964).

Participants: Adults with glaucoma managed with at least a fixed combination of timolol/dorzolamide who are adherent to treatment.